Successful Antiviral Therapy Reduces Risk of Schizophrenia Among Chronic Hepatitis C Patients: A Nationwide Real-World Taiwanese Cohort (T-COACH).

Pei-Chien TsaiChi-Yi ChenHsing-Tao KuoChao-Hung HungKuo-Chih TsengHsueh-Chou LaiCheng-Yuan PengJing-Houng WangJyh-Jou ChenPei-Lun LeeRong-Nan ChienChi-Chieh YangGin-Ho LoJia-Horng KaoChun-Jen LiuChen-Hua LiuSheng-Lei YanMing-Jong BairChun-Yen LinWei-Wen SuCheng-Hsin ChuChih-Jen ChenShui-Yi TungChi-Ming TaiChih-Wen LinChing-Chu LoPin-Nan ChengYen-Cheng ChiuChia-Chi WangJin-Shiung ChengWei-Lun TsaiHan-Chieh LinYi-Hsiang HuangMing-Lun YehChung-Feng HuangMeng-Hsuan HsiehJee-Fu HuangChia-Yen DaiWan-Long ChungChiao-Li Khale KeMing-Lung Yu

Published in: Open forum infectious diseases (2020)

Successful IFN-based therapy might reduce the incidence of schizophrenia among CHC patients, especially among younger patients.

Keyphrases

end stage renal disease
chronic kidney disease
ejection fraction
newly diagnosed
prognostic factors
peritoneal dialysis
bipolar disorder
immune response
patient reported outcomes
patient reported
cross sectional